BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2698561)

  • 1. [Treatment of stress-induced and spontaneous myocardial ischemia in coronary disease patients with slow-release gallopamil--preliminary results of an open study].
    Steinbeck C; Reuschel-Janetschek E; von Arnim T
    Z Kardiol; 1989; 78 Suppl 5():103-7. PubMed ID: 2698561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Slow-release gallopamil evaluated by exercise test and long-term electrocardiography.
    Steinbeck G; Reuschel-Janetschek E
    J Cardiovasc Pharmacol; 1992; 20 Suppl 7():S83-7. PubMed ID: 1284162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of 75 mg retard gallopamil on stress-induced myocardial ischemia].
    Sinn R; Wolf R
    Z Kardiol; 1989; 78 Suppl 5():83-8. PubMed ID: 2698568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effectiveness of retard gallopamil in patients with stress-induced ST-segment depression and silent myocardial ischemias].
    Barbato G; Klein H; Lichtlen PR
    Z Kardiol; 1989; 78 Suppl 5():98-102. PubMed ID: 2698571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic coronary effectiveness of retard gallopamil following repeated administration in comparison with placebo].
    Loskot F; Novotny P; Sucic P; Schneider G
    Z Kardiol; 1989; 78 Suppl 5():89-93. PubMed ID: 2698569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The anti-ischemic effect of gallopamil-retard in comparison with nifedipine-retard in stable angina pectoris].
    Rettig GF; Jakob M; Koch HP
    Z Kardiol; 1992 Oct; 81(10):525-30. PubMed ID: 1441691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of slow-release gallopamil in patients with stable exercise-inducible angina pectoris.
    Kottkamp H; Gülker H; Emmerich K; Koch HP; Minge C
    J Cardiovasc Pharmacol; 1992; 20 Suppl 7():S88-94. PubMed ID: 1284163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exercise-induced symptomatic and asymptomatic myocardial ischemia in patients with severe coronary artery disease: focus on the efficacy and safety of gallopamil.
    Zehender M; Kosscheck U; Hohnloser S; Weiss C; Meinertz T; Just H
    J Cardiovasc Pharmacol; 1992; 20 Suppl 7():S57-63. PubMed ID: 1284158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Exercise capacity of coronary heart disease patients in long-term follow-up with gallopamil in comparison with premedication with verapamil].
    Reiterer W
    Z Kardiol; 1989; 78 Suppl 5():63-8. PubMed ID: 2517157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Long-term treatment of stable angina pectoris with gallopamil].
    Pupita G; Mattei O; Mazzara D; Centanni M; Ferretti GF; Rimatori C; Dessì-Fulgheri P; Rappelli A; Russo P
    G Ital Cardiol; 1992 Sep; 22(9):1049-56. PubMed ID: 1291422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Randomized comparison between gallopamil and diltiazem in angiography verified coronary heart disease].
    Zenker GD; Rödl S; Genger K
    Z Kardiol; 1989; 78 Suppl 5():94-7. PubMed ID: 2698570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Value of stress and long-term ECG in the diagnosis of silent myocardial ischemia in patients with coronary heart disease].
    Hausmann D; Nikutta P; Daniel WG; Hartwig CA; Wenzlaff P; Lichtlen PR
    Z Kardiol; 1988 May; 77(5):282-90. PubMed ID: 3407272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracoronary gallopamil during percutaneous transluminal coronary angioplasty.
    Rauch B; Richardt G; Barth R; Zimmermann R; Tillmanns H; Schömig A; Kübler W; Neumann FJ
    J Cardiovasc Pharmacol; 1992; 20 Suppl 7():S32-9. PubMed ID: 1284155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy and duration of effect of two delayed-action preparations of gallopamil in patients with exercise angina].
    Pucci P; Fantoccoli D; Dovellini EV; Leoncini M; Sarro F; Fazzini PF
    G Ital Cardiol; 1990 Jun; 20(6):526-32. PubMed ID: 2227222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gallopamil and molsidomine in patients with coronary heart disease. A comparative study].
    Zebe H
    Fortschr Med; 1989 Feb; 107(5):134-8. PubMed ID: 2651251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ten-year mortality rate in relation to observations at a bicycle exercise test in patients with a suspected or confirmed ischemic event but no or only minor myocardial damage: influence of subsequent revascularization.
    Karlson BW; Sjölin M; Lindqvist J; Caidahl K; Herlitz J
    Am Heart J; 2001 Jun; 141(6):977-84. PubMed ID: 11376313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dose-response relation of gallopamil in comparison with nifedipine, diltiazem and tiapamil in patients with coronary heart disease].
    Hopf R; Fleischer K; Forster A; Mohler C; Schulz PC; Kaltenbach M
    Z Kardiol; 1989; 78 Suppl 5():69-76. PubMed ID: 2698566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of ischemic heart disease in the elderly. Comparison of diltiazem, verapamil and gallopamil].
    Simonelli P; Papa A; Macciocchi B; Auriemma F; Vetrano A; Scaletta Romeo di Santillo M; Ceriello A
    Minerva Cardioangiol; 1993 May; 41(5):193-204. PubMed ID: 8355859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dose-response relationship of nisoldipine in patients with stable angina pectoris and stress-induced myocardial ischemia].
    Grönefeld G; Bernhardt J; Schneider W
    Z Kardiol; 1993 Sep; 82(9):573-8. PubMed ID: 8237098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [High-dose single administration of isosorbide dinitrate: effect on diurnal distribution of transitory myocardial ischemia in patients with stable angina pectoris].
    Hausmann D; Nikutta P; Daniel WG; Hartwig CA; Wenzlaff P; Lichtlen PR
    Z Kardiol; 1989 Jul; 78(7):415-20. PubMed ID: 2672651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.